Prenetics Global Limited (PRE) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Prenetics Global Limited (PRE)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.81

0.02 (0.43%)

At close: Jan 14, 2025, 3:55 PM

5.81

0.00%

After-hours Jan 14, 2025, 03:56 PM EST

undefined% (undefined)

Bid	2.36
Market Cap	70.98M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-3.73
PE Ratio (ttm)	-1.56
Forward PE	n/a
Analyst	Buy

Ask	6.06
Volume	4,359
Avg. Volume (20D)	11,532
Open	5.86
Previous Close	5.79
Day's Range	5.44 - 5.99
52-Week Range	2.85 - 7.84
Beta	undefined

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jul 16, 2021

Employees 320

Stock Exchange NASDAQ

Ticker Symbol PRE

Website https://www.prenetics.com

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 54.91% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 months ago · Source

+19.13%

Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription

4 months ago · Source

+5.47%

Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.

News

1 year ago · zacks.com

Wall Street Analysts See Prenetics Global Limited (PRE) as a Buy: Should You Invest?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

1 year ago · zacks.com

Should You Invest in Prenetics Global Limited (PRE) Based on Bullish Wall Street Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy...

1 year ago · investorplace.com

7 Stocks to Buy for Their Massive Upside Potential

If Warren Buffett was your financial advisor, he might steer you toward reliable blue-chip investments, not wildly speculative stocks to buy now. Put another way, you're probably not going to find the...

1 year ago · zacks.com

Prenetics Global Limited (PRE) Flat As Market Gains: What You Should Know

Prenetics Global Limited (PRE) closed the most recent trading day at $0.89, making no change from the previous trading session.

1 year ago · zacks.com

Prenetics Global Limited (PRE) Loses -24.21% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Prenetics Global Limited (PRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earn...

2 years ago · pennystocks.com

Can Penny Stocks Make You Money Right Now?

Can you make money trading penny stocks in 2023? The post Can Penny Stocks Make You Money Right Now?

2 years ago · fool.com

Why Prenetics Global Stock Is Skyrocketing Today

The company announced a key FDA clearance.